MERCHAVIA MEDICAL DISTRIBUTION
Merchavia MDM (medical distribution management) arm provides innovative, integrated medical products and services distribution channels in one of the fastest development regions in the world – the Middle East, with a Headquarter in Israel. We integrate the best global trusted advisors and consultants into our management. Enabling us to deliver the best quality strategical and pathway for success in this unique business region by enhancing the practice of basic distribution management efficiency and profitability.
WHY IT IS WORKING SO WELL
It is well known that what works in distribution strategy in America does not always work in Western Europe, and what works in Europe do not always work in the Middle East. Merchavia MDM blends the local medical business culture, the region’s healthcare practice, local KOL perspectives, specific healthcare region regulations and reforms, and most importantly, the healthcare market behavior. This blend gives the Edge for success to our global customers.
SHOW ME THE EVIDENCE
Merchavia MDM has exclusive distribution rights in the region for a unique prostate cancer early-detection diagnostic IsoPSA test. Cleveland DX developed the test using a first-in-class liquid biopsy platform focusing on changes to the structure of proteins in circulating fluids – precise to cancer.
Cleveland DX IsoPSA test is included in NCCN and European guidelines and received FDA Breakthrough Device Designation. IsoPSA has gone through extensive scientific research validation, and we believe it is the most versatile prostate cancer diagnostic test available. IsoPSA is also very complementary to MRI-based diagnostic pathways. With Merchavia MDM the introduction to our markets has been professional, fast round to arrive at first sales and increasing in rapid sales in 2022.
For new healthcare product distribution inquiries, including requests for representation and strategic business cases, contact:
Eli Arad Eli@merchavia.com